Aigen Investment Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,499
Closed -$602K 779
2022
Q4
$602K Buy
26,499
+15,237
+135% +$424K 0.09% 233
2022
Q3
$384K Buy
+11,262
New +$416K 0.06% 357

Other funds holding PRVA

Aigen Investment Management's PRVA Position: Q1 2023 in Review

Aigen Investment Management sold out of Privia Health (PRVA) in Q1 2023, closing a stake of 26,499 shares — an estimated $602K sold.

Aigen Investment Management first reported a position in PRVA in Q3 2022 and held it in 2 quarters. The position peaked at $602K in Q4 2022. 191 funds tracked by Wall St. Rank hold PRVA as of Q1 2023.

  • Aigen Investment Management reported no remaining Privia Health position as of Q1 2023 after selling out during the quarter.
  • Aigen Investment Management sold 26,499 Privia Health shares in Q1 2023, an estimated $602K.
  • Aigen Investment Management first reported a position in Privia Health in Q3 2022 and held it in 2 quarters.
  • Aigen Investment Management's Privia Health position peaked at $602K in Q4 2022.
  • 191 funds tracked by Wall St. Rank held Privia Health as of Q1 2023.

Based on Aigen Investment Management's 13F filing for Q1 2023, filed 15 May 2023.